Progressive right ventricular functional and structural changes in a mouse model of pulmonary arterial hypertension

Physiological Reports

Volumn 1, Issue 7, 2013, Pages

  Wang, Zhijie ^a   Schreier, David A ^a   Hacker, Timothy A ^b   Chesler, Naomi C ^a,b  

^a Wisconsin Electric Machines and Power Electronics Consortium   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

RV dysfunction; RV overload; SUGEN; Ventricular vascular coupling

Indexed keywords

SEMAXANIB;

ANIMAL MODEL; AORTA PRESSURE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FIBROSIS; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE PRESSURE; HEART RIGHT VENTRICLE VOLUME; HEART STROKE VOLUME; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE REMODELING; HEMATOCRIT; HEMODYNAMIC PARAMETERS; HYPOXIA; LUNG BLOOD VESSEL; MALE; MOUSE; NONHUMAN; PULMONARY HYPERTENSION;

EID: 85008939517     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.184     Document Type: Article

References (41)

1. Abe, K., M. Toba, A. Alzoubi, M. Ito, K. A. Fagan, C. D. Cool, et al. 2010. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation 121:2747-2754.
2. Baicu, C. F., J. D. Stroud, V. A. Livesay, E. Hapke, J. Holder, F. G. Spinale, et al. 2003. Changes in extracellular collagen matrix alter myocardial systolic performance. Am. J. Physiol. Heart Circ. Physiol. 284:H122-H132.
3. Bogaard, H. J., K. Abe, A. Vonk Noordegraaf, and N. F. Voelkel. 2009a. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 135:794-804.
4. Bogaard, H. J., R. Natarajan, S. C. Henderson, C. S. Long, D. Kraskauskas, L. Smithson, et al. 2009b. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120:1951-1960.
5. Ciuclan, L., O. Bonneau, M. Hussey, N. Duggan, A. M. Holmes, R. Good, et al. 2011. A novel murine model of severe pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 184:1171-1182.
6. D’Alonzo, G. E., R. J. Barst, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, et al. 1991. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med. 115:343-349.
7. Gomez-Arroyo, J., S. J. Saleem, S. Mizuno, A. A. Syed, H. J. Bogaard, A. Abbate, et al. 2012. A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am. J. Physiol. Lung Cell. Mol. Physiol. 302: L977-L991.
8. Guazzi, M., M. Vicenzi, R. Arena, and M. D. Guazzi. 2011. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 124:164-174.
9. Gupta, H., G. Ghimire, and R. Naeije. 2011. The value of tools to assess pulmonary arterial hypertension. Eur. Respir. Rev. 20:222-235.
10. Humbert, M., O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, V. Gressin, et al. 2010. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156-163.
11. Janicki, J. S., G. L. Brower, J. D. Gardner, M. F. Forman, J. A. Jr Stewart, D. B. Murray, et al. 2006. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc. Res. 69:657-665.
12. Kawut, S. M., E. M. Horn, K. K. Berekashvili, R. P. Garofano, R. L. Goldsmith, A. C. Widlitz, et al. 2005. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am. J. Cardiol. 95:199-203.
13. Kerckhoffs, R. C. P., P. H. M. Bovendeerd, F. W. Prinzen, K. Smits, and T. Arts. 2003. Intra-and interventricular asynchrony of electromechanics in the ventricularly paced heart. J. Eng. Math. 47:201-216.
14. Kuehne, T., S. Yilmaz, P. Steendijk, P. Moore, M. Groenink, M. Saaed, et al. 2004. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 110:2010-2016.
15. Lopez, B., R. Querejeta, A. Gonzalez, M. Larman, and J. Diez. 2012. Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase. Hypertension 60:677-683.
16. McLaughlin, V. V., S. L. Archer, D. B. Badesch, R. J. Barst, H. W. Farber, J. R. Lindner, et al. 2009. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119:2250-2294.
17. Nicolls, M. R., S. Mizuno, L. Taraseviciene-Stewart, L. Farkas, J. I. Drake, A. Al Husseini, et al. 2012. New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis. Pulm. Circ. 2: 434-442.
18. Ooi, C. Y., Z. Wang, D. M. Tabima, J. C. Eickhoff, and N. C. Chesler. 2010. The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 299:H1823-H1831.
19. Pacher, P. N. T., P. Mukhopadhyay, S. Batkai, and D. A. Kass. 2008. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat. Protoc. 3:1422-1434.
20. Persson, S. U., C. G. Gustavsson, H. Larsson, and S. Persson. 1991. Studies on blood rheology in patients with primary pulmonary hypertension. Angiology 42:836-842.
21. Porterfield, J. E. K. A., K. Raghavan, D. Escobedo, J. T. Jenkins, E. R. Larson, R. J. Trevino, et al. 2009. Dynamic correction for parallel conductance, GP, and gain factor, alpha, in invasive murine left ventricular volume measurements. J. Appl. Physiol. 107:1693-1703.
22. Rain, S., M. L. Handoko, P. Trip, T. J. Gan, N. Westerhof, G. Stienen, et al. 2013. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 128:2016-2025.
23. Ripoll, V. M., N. A. Meadows, M. Bangert, A. W. Lee, A. Kadioglu, and R. D. Cox. 2012. Nicotinamide nucleotide transhydrogenase (NNT) acts as a novel modulator of macrophage inflammatory responses. FASEB J. 26: 3550-3562.
24. Sanz, J., S. Dellegrottaglie, M. Kariisa, R. Sulica, M. Poon, T. P. O’Donnell, et al. 2007. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am. J. Cardiol. 100: 731-735.
25. Sanz, J., A. Garcia-Alvarez, L. Fernandez-Friera, A. Nair, J. G. Mirelis, S. T. Sawit, et al. 2012. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 98:238-243.
26. Schreier, D. A., T. A. Hacker, G. Song, and N. C. Chesler. 2013. Impact of blood viscosity on right ventricular afterload during hypoxic pulmonary hypertension. P. 111 in Biomedical Engineering Society Conference, BMES Annual Meeting, Seattle, WA, 25-28 September 2013.
27. Shehata, M. L., D. Lossnitzer, J. Skrok, D. Boyce, N. Lechtzin, S. C. Mathai, et al. 2011. Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am. J. Roentgenol. 196:87-94.
28. Sutendra, G., P. Dromparis, R. Paulin, S. Zervopoulos, A. Haromy, J. Nagendran, et al. 2013. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J. Mol. Med. (Berl) 91:1315-1327.
29. Tabima, D. M., T. A. Hacker, and N. C. Chesler. 2010. Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops. Am. J. Physiol. Heart Circ. Physiol. 299:H2069-H2075.
30. Taraseviciene-Stewart, L., Y. Kasahara, L. Alger, P. Hirth, G. Mc Mahon, J. Waltenberger, et al. 2001. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 15:427-438.
31. Tewari, S. G., S. M. Bugenhagen, Z. Wang, D. A. Schreier, B. E. Carlson, N. C. Chesler, et al. 2013. Analysis of cardiovascular dynamics in pulmonary hypertensive C57BL6/J mice. Frontiers (companion paper in press) 4. doi: 10.3389/fphys.2013.00355.
32. van de Veerdonk, M. C., T. Kind, J. T. Marcus, G. J. Mauritz, M. W. Heymans, H. J. Bogaard, et al. 2011. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J. Am. Coll. Cardiol. 58:2511-2519.
33. Vinnakota, K. C., and J. B. Bassingthwaighte. 2004. Myocardial density and composition: a basis for calculating intracellular metabolite concentrations. Am. J. Physiol. Heart Circ. Physiol. 286:H1742-H1749.
34. Voelkel, N. F., R. A. Quaife, L. A. Leinwand, R. J. Barst, M. D. McGoon, D. R. Meldrum, et al. 2006. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114:1883-1891.
35. Voelkel, N. F., J. Gomez-Arroyo, A. Abbate, H. J. Bogaard, and M. R. Nicolls. 2012. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur. Respir. J. 40:1555-1565.
36. Wang, Z., and N. C. Chesler. 2011. Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm. Circ. 1:212-223.
37. Wang, Z., and N. C. Chesler. 2012. Role of collagen content and cross-linking in large pulmonary arterial stiffening after chronic hypoxia. Biomech. Model. Mechanobiol. 11:279-289.
38. Wang, Z., R. S. Lakes, J. C. Eickhoff, and N. C. Chesler. 2013. Effects of collagen deposition on passive and active mechanical properties of large pulmonary arteries in hypoxic pulmonary hypertension. Biomech. Model. Mechanobiol. 12:1115-1125.
39. Weber, K. T. 1989. Cardiac interstitium in health and disease: the fibrillar collagen network. J. Am. Coll. Cardiol. 13:1637-1652.
40. Weber, K. T., J. S. Janicki, S. G. Shroff, R. Pick, R. M. Chen, and R. I. Bashey. 1988. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ. Res. 62:757-765.
41. van Wolferen, S. A., J. T. Marcus, A. Boonstra, K. M. Marques, J. G. Bronzwaer, M. D. Spreeuwenberg, et al. 2007. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur. Heart J. 28:1250-1257.